Ochre Bio

📍 Oxford, United Kingdom🗓 Founded 2019👥 62 employees💰 Last funded Aug 2023
Ochre Bio is a biotechnology company developing RNA therapies for chronic liver diseases. Using a combination of genomic deep phenotyping, precision RNA medicine, and testing in live human donor livers, Ochre is developing therapies for important liver health challenges, from increasing donor liver supply to reducing cirrhosis complications. To learn more, please visit www.ochre-bio.com.
6
Total investors
4
Early stage
2
Mid stage
0
Late stage
2019
Founded
Investor geography2 countries
United Kingdom
3
United States
3
Investor activity2019–2023 · investors recorded per year
2019120201202122022120231
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Ochre Bio?
Ochre Bio has 6 investors on record on gritt.io, including 4 early-stage backers, 2 mid-stage.
When did Ochre Bio last raise funding?
The most recent investment in Ochre Bio recorded on gritt.io was in August 2023.
When was Ochre Bio founded?
Ochre Bio was founded in 2019.
What industry is Ochre Bio in?
Ochre Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Ochre Bio based?
Ochre Bio is headquartered in Oxford, United Kingdom.